Clinica Universitaria de Navarra Madrid

Madrid 28027

1 studies enrolling now · 4 studies all time

What they study most

Advanced Colorectal Cancer, Bladder Cancer, Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Metastatic Urothelial Carcinoma, Muscle Invasive Bladder Cancer, Myelodysplastic Syndromes (MDS), Non-small Cell Lung Cancer (NSCLC), Renal Pelvis Carcinoma, Ureter Carcinoma, Urethra Carcinoma, Urinary Bladder Carcinoma, Urothelial Carcinoma

Studies at this site

• Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation — Recruiting now
• Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer — Completed
• Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma — Stopped early